ARGUS II RETINAL PROSTHESIS 011014-001-K 011014

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2016-04-03 for ARGUS II RETINAL PROSTHESIS 011014-001-K 011014 manufactured by Second Sight Medical Products, Inc..

Event Text Entries

[41715097] All pertinent information available to second sight medical products, inc. Has been submitted. The company is submitting this mdr to ensure full compliance with 21 cfr part 803.
Patient Sequence No: 1, Text Type: N, H10


[41715098] Patient (b)(6) was implanted with the argus ii device on (b)(6) 2015. The patient reported pain in the implanted eye since (b)(6) 2016. The surgeon noted hypotony and hyphema in the implanted eye. On (b)(6) 2016, the patient underwent revision surgery during which blood was removed from the anterior chamber of the eye. Anti-vascular endothelial growth factor drugs as well as antibiotics and glucocorticoids were injected into the eye. In addition, fibrotic tissue present on the anterior and posterior surfaces of the intraocular lens was removed. The surgeon observed vitreous hemorrhage as well as extensive neovascularization of the iris, and likely the ciliary body region. The electrode array of the device was in a good position, the retinal tack was secure, and the retina was attached. No leak in the eye could be found. The surgeon reported that the patient's eye may be "prephthisical. " the patient's intraocular pressure continues to be low. The patient is on topical steroids and atropine drops and has been scheduled for another revision surgery on (b)(6) 2016.
Patient Sequence No: 1, Text Type: D, B5


[44474183] This event represents a follow-up report after the revision surgery that was reported in mdr# 3004081696-2016-00003. All pertinent information available to second sight medical products, inc. Has been submitted. The company is submitting this mdr to ensure full compliance with 21 cfr part 803.
Patient Sequence No: 1, Text Type: N, H10


[44474184] This patient experienced hypotony and hyphema in the implanted eye, and underwent a revision surgery on (b)(6) 2016. During surgery, the surgeon observed vitreous hemorrhage as well as neovascularization of the iris and ciliary body region. New information: on (b)(6) 2016, the surgeon reported that the neovascularization had regressed, but the vitreous hemorrhage and low intraocular pressure (iop) were still present. On (b)(6) 2016, the patient underwent a second revision surgery during which a vitrectomy and injection of silicone oil were performed. On (b)(6) 2016, the patient came in for a follow-up visit during which it was reported that the patient's anterior chamber was deep, and that there was no hyphema or neovascularization present. Patient's iol was reported to be in a good positon, vitreous was clear, and retina was attached. The electrode array was in a good position as well. Patient has no pain but continues to have hypotony, and remains on prescribed steroids.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3004081696-2016-00003
MDR Report Key5543509
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2016-04-03
Date of Report2016-03-03
Date of Event2016-02-29
Date Mfgr Received2016-03-03
Device Manufacturer Date2013-07-31
Date Added to Maude2016-04-03
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. MARK LOAR
Manufacturer Street12744 SAN FERNANDO RD. SUITE 400
Manufacturer CitySYLMAR CA 91342
Manufacturer CountryUS
Manufacturer Postal91342
Manufacturer Phone8188335049
Manufacturer G1SECOND SIGHT MEDICAL PRODUCTS, INC.
Manufacturer Street12744 SAN FERNANDO RD. SUITE 400
Manufacturer CitySYLMAR CA 91342
Manufacturer CountryUS
Manufacturer Postal Code91342
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARGUS II RETINAL PROSTHESIS
Generic NameRETINAL PROSTHESIS
Product CodeNBF
Date Received2016-04-03
Model Number011014-001-K
Catalog Number011014
Lot NumberN/A
Device Expiration Date2015-07-31
OperatorPHYSICIAN
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSECOND SIGHT MEDICAL PRODUCTS, INC.
Manufacturer Address12744 SAN FERNANDO RD. SUITE 400 SYLMAR CA 91342 US 91342


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2016-04-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.